You have 9 free searches left this month | for more free features.

Chromophobe

Showing 1 - 25 of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

Recruiting
  • Kidney Cancer
  • +11 more
  • 13C-Glucose
  • +4 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma

Recruiting
  • Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 2, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +10 more
Feb 14, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Active, not recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +18 more
Feb 14, 2022

Biomarkers of Renal Cancer

Recruiting
  • Renal Cell Carcinoma
  • +3 more
    • Firenze, Italy
    • +3 more
    Mar 14, 2023

    Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

    Recruiting
    • Advanced Renal Cell Carcinoma
    • +8 more
    • Cabozantinib S-malate
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Jan 24, 2023

    Renal Cancer, Birt-Hogg-Dube Syndrome Trial run by the NCI (Everolimus)

    Terminated
    • Renal Cancer
    • Birt-Hogg-Dube Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 7, 2019

    Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

    Recruiting
    • Non-clear Renal Cell Carcinoma
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 13, 2023

    Urothelial Cancer and Rare Genitourinary Tract Malignancies

    Recruiting
    • Urothelial Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Von Hippel-Lindau: Clinical Manifestations, Diagnosis,

      Recruiting
      • Kidney Cancer
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for

        Not yet recruiting
        • Kidney Tumor
        • +2 more
          • (no location specified)
          Feb 6, 2023

          Brain and CNS Tumors Trial (drug, genetic, other)

          Withdrawn
          • Brain and Central Nervous System Tumors
          • (no location specified)
          Jul 29, 2020

          Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States

          Recruiting
          • Bladder Adenocarcinoma
          • +45 more
          • Cabozantinib S-malate
          • +2 more
          • Birmingham, Alabama
          • +563 more
          Aug 24, 2022

          Metastatic Renal Cell Carcinoma Trial in Spain

          Completed
          • Metastatic Renal Cell Carcinoma
            • Ferrol, A Coruña, Spain
            • +22 more
            Oct 6, 2021

            Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-176)

            Terminated
            • Advanced Solid Tumors Cancer
            • Scottsdale, Arizona
            • +10 more
            Nov 28, 2018

            Renal Cell Carcinoma Trial (Immunohistochemistry)

            Unknown status
            • Renal Cell Carcinoma
            • Immunohistochemistry
            • (no location specified)
            Sep 29, 2018

            Perfusion Scanning's for Kidney Tumors

            Completed
            • Kidney Cancer
              • Roskilde, Denmark
                Roskilde Hospital
              Jan 22, 2018

              Advanced Non-clear Cell Renal Cell Carcinoma Trial in Canada, United Kingdom, United States (Everolimus, Sunitinib)

              Completed
              • Advanced Non-clear Cell Renal Cell Carcinoma
              • Chicago, Illinois
              • +17 more
              Dec 15, 2017

              Diabetes Trial in Worldwide (Albiglutide 30 mg, Albiglutide 50 mg, Albiglutide matching )

              Completed
              • Diabetes Mellitus
              • Albiglutide 30 mg
              • +2 more
              • Birmingham, Alabama
              • +607 more
              Feb 11, 2019

              Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma Trial in Seoul (pazopanib)

              Completed
              • Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma
              • Seoul, Korea, Republic of
                Samsung medical Center
              Apr 24, 2017

              Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in Boston, Philadelphia,

              Completed
              • Chromophobe Renal Cell Carcinoma
              • +5 more
              • Bevacizumab
              • +3 more
              • Boston, Massachusetts
              • +4 more
              Jan 6, 2015

              Renal Cell Cancer, Kidney Cancer Trial in Houston (Sunitinib Malate)

              Completed
              • Renal Cell Cancer
              • Kidney Cancer
              • Sunitinib Malate
              • Houston, Texas
                University of Texas MD Anderson Cancer Center
              May 4, 2016

              Kidney Tumors Trial in France (surgery or biopsy of the kidney tumor)

              Terminated
              • Kidney Neoplasms
              • surgery or biopsy of the kidney tumor
              • Grenoble, France
              • +6 more
              Jun 3, 2015

              Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood CNS Choriocarcinoma, Childhood CNS Germinoma Trial in Canada, United

              Terminated
              • Childhood Atypical Teratoid/Rhabdoid Tumor
              • +45 more
              • gamma-secretase/Notch signalling pathway inhibitor RO4929097
              • +3 more
              • Palo Alto, California
              • +11 more
              Nov 4, 2014